Lista de obras -

A Sulfonozanamivir Analogue has Potent Anti-influenza Virus Activity.

artículo científico publicado en 2018

A secondary sialic acid binding site on influenza virus neuraminidase: fact or fiction?

artículo científico publicado en 2012

A sialosyl sulfonate as a potent inhibitor of influenza virus replication

artículo científico publicado en 2017

Affinity of vitamin E analogues for the ubiquinone complex II site correlates with their toxicity to cancer cells

artículo científico publicado en 2011

Binding of a natural anthocyanin inhibitor to influenza neuraminidase by mass spectrometry

artículo científico publicado en 2013

Complexity in influenza virus targeted drug design: interaction with human sialidases.

artículo científico publicado en 2010

Cracking the code for H5N1-bird flu and beyond.

artículo científico publicado en 2009

Exploring human parainfluenza virus type-1 hemagglutinin-neuraminidase as a target for inhibitor discovery

artículo científico publicado en 2014

Exploring the Interactions of Unsaturated Glucuronides with Influenza Virus Sialidase ⬇️

artículo científico publicado el 11 de octubre de 2012

Functional and structural characterization of a heparanase

artículo científico publicado en 2015

Influenza C virus and bovine coronavirus esterase reveal a similar catalytic mechanism: new insights for drug discovery

artículo científico publicado en 2008

Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II.

artículo científico publicado en 2007

Mitochondrial targeting of vitamin E succinate enhances its pro-apoptotic and anti-cancer activity via mitochondrial complex II

artículo científico publicado en 2010

Modelling, synthesis and biological evaluation of novel glucuronide-based probes of Vibrio cholerae sialidase.

artículo científico publicado en 2005

NMR spectroscopic and molecular modeling investigations of the trans-sialidase from Trypanosoma cruzi.

artículo científico publicado en 2004

Novel 3,4-disubstituted-Neu5Ac2en derivatives as probes to investigate flexibility of the influenza virus sialidase 150-loop.

artículo científico publicado en 2013

Novel sialic acid derivatives lock open the 150-loop of an influenza A virus group-1 sialidase

artículo científico publicado en 2010

Novel structural insights into rotavirus recognition of ganglioside glycan receptors

artículo científico publicado en 2011

Recognition of the GM3 ganglioside glycan by Rhesus rotavirus particles

artículo científico publicado en 2011

Sialic acid dependence in rotavirus host cell invasion

artículo científico publicado en 2008

Structural analysis of a designed inhibitor complexed with the hemagglutinin-neuraminidase of Newcastle disease virus

artículo científico publicado en 2006

Structure-guided discovery of potent and dual-acting human parainfluenza virus haemagglutinin-neuraminidase inhibitors

artículo científico publicado en 2014

Synthesis and evaluation of 4-O-alkylated 2-deoxy-2,3-didehydro-N-acetylneuraminic acid derivatives as inhibitors of human parainfluenza virus type-3 sialidase activity

artículo científico publicado en 2007

Synthesis and evaluation of novel 3-C-alkylated-Neu5Ac2en derivatives as probes of influenza virus sialidase 150-loop flexibility

artículo científico publicado en 2012

Unsaturated N-acetyl- D-glucosaminuronic acid glycosides as inhibitors of influenza virus sialidase.

artículo científico publicado en 2006

Vitamin E analogues as a novel group of mitocans: anti-cancer agents that act by targeting mitochondria

artículo científico publicado en 2007

Lista de obras de

A Sulfonozanamivir Analogue has Potent Anti-influenza Virus Activity.

A secondary sialic acid binding site on influenza virus neuraminidase: fact or fiction?

A sialosyl sulfonate as a potent inhibitor of influenza virus replication

Affinity of vitamin E analogues for the ubiquinone complex II site correlates with their toxicity to cancer cells

Binding of a natural anthocyanin inhibitor to influenza neuraminidase by mass spectrometry

Complexity in influenza virus targeted drug design: interaction with human sialidases.

Cracking the code for H5N1-bird flu and beyond.

Exploring human parainfluenza virus type-1 hemagglutinin-neuraminidase as a target for inhibitor discovery

Exploring the Interactions of Unsaturated Glucuronides with Influenza Virus Sialidase ⬇️

Functional and structural characterization of a heparanase

Influenza C virus and bovine coronavirus esterase reveal a similar catalytic mechanism: new insights for drug discovery

Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II.

Mitochondrial targeting of vitamin E succinate enhances its pro-apoptotic and anti-cancer activity via mitochondrial complex II

Modelling, synthesis and biological evaluation of novel glucuronide-based probes of Vibrio cholerae sialidase.

NMR spectroscopic and molecular modeling investigations of the trans-sialidase from Trypanosoma cruzi.

Novel 3,4-disubstituted-Neu5Ac2en derivatives as probes to investigate flexibility of the influenza virus sialidase 150-loop.

Novel sialic acid derivatives lock open the 150-loop of an influenza A virus group-1 sialidase

Novel structural insights into rotavirus recognition of ganglioside glycan receptors

Recognition of the GM3 ganglioside glycan by Rhesus rotavirus particles

Sialic acid dependence in rotavirus host cell invasion

Structural analysis of a designed inhibitor complexed with the hemagglutinin-neuraminidase of Newcastle disease virus

Structure-guided discovery of potent and dual-acting human parainfluenza virus haemagglutinin-neuraminidase inhibitors

Synthesis and evaluation of 4-O-alkylated 2-deoxy-2,3-didehydro-N-acetylneuraminic acid derivatives as inhibitors of human parainfluenza virus type-3 sialidase activity

Synthesis and evaluation of novel 3-C-alkylated-Neu5Ac2en derivatives as probes of influenza virus sialidase 150-loop flexibility

Unsaturated N-acetyl- D-glucosaminuronic acid glycosides as inhibitors of influenza virus sialidase.

Vitamin E analogues as a novel group of mitocans: anti-cancer agents that act by targeting mitochondria